[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]methanone
C18H22ClF3N2O3S — CID 94117035
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]methanone
[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]methanone (PubChem CID 94117035) has the molecular formula C18H22ClF3N2O3S and a molecular weight of 438.90 g/mol. Its IUPAC name is [4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]methanone.
Molecular Properties
| Compound Name | [4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]methanone |
|---|---|
| PubChem CID | 94117035 |
| Molecular Formula | C18H22ClF3N2O3S |
| Molecular Weight | 438.90 g/mol |
| Exact Mass | 438.10 |
| IUPAC Name | [4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]methanone |
| SMILES | O=C([C@H]1CCC[C@@H](C(F)(F)F)C1)N1CCN(S(=O)(=O)c2cccc(Cl)c2)CC1 |
| InChI | InChI=1S/C18H22ClF3N2O3S/c19-15-5-2-6-16(12-15)28(26,27)24-9-7-23(8-10-24)17(25)13-3-1-4-14(11-13)18(20,21)22/h2,5-6,12-14H,1,3-4,7-11H2/t13-,14+/m0/s1 |
| InChIKey | UGGBCGVFQRHIKT-UONOGXRCSA-N |
| XLogP | 3.54 |
| TPSA | 57.69 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.90 |
| LogP ≤ 5 | 3.54 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 94117035 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.